针对上述提问，三星医疗回应称："尊敬的投资者，您好！公司主营业务为智能配用电及医疗服务两大 板块，未涉及可控核聚变领域。感谢您的关注！" 有投资者在互动平台向三星医疗提问："贵司是否涉及可控核聚变领域？" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 ...

格隆汇12月23日丨三星医疗(601567.SH)在投资者互动平台表示，公司主营业务为智能配用电及医疗服 务两大板块，未涉及可控核聚变领域。 ...

Overview of Guarantees - The company has signed a guarantee contract with Bank of Communications for a maximum principal amount of RMB 440 million, effective from December 1, 2025, to December 1, 2030 [1] - The company has also signed a maximum guarantee contract with Agricultural Bank of China for a maximum principal amount of RMB 675 million, effective from December 10, 2025, to December 9, 2028 [1] - The company applied for a letter of guarantee from Standard Chartered Bank for USD 100,000 (approximately RMB 716,200), with an initial validity until April 10, 2026, which has been extended to May 15, 2026 [2] Internal Decision-Making Process - The company’s board of directors approved the guarantee proposals on April 24, 2025, and the annual shareholders' meeting on May 16, 2025, allowing for a total guarantee amount of up to RMB 974.85 million, with RMB 450 million specifically for the subsidiary [2] Financial Health of the Guaranteed Entity - The subsidiary, Aux Smart Technology, has a debt-to-asset ratio of 68.93% as of the end of 2024, indicating a significant level of leverage [2] Details of Guarantee Agreements - The guarantee to Bank of Communications covers all principal debts and associated costs, with a maximum guarantee amount of RMB 440 million [4][5] - The guarantee to Agricultural Bank of China also includes all principal debts and associated costs, with a maximum guarantee amount of RMB 675 million [7][8] Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to meet the funding needs of the subsidiary and ensure its stable operations, with the company maintaining control over the subsidiary's financial health [9] Board of Directors' Opinion - The board believes that providing guarantees to the subsidiary is based on actual operational needs and that the associated risks are manageable [10] Cumulative Guarantee Amounts - As of the announcement date, the total amount of guarantees provided by the company to its subsidiaries is RMB 975.35 million, which represents 80.73% of the company's net assets attributable to shareholders for the year 2024 [10]

证券代码：601567 证券简称：三星医疗 公告编号：临2025-095 宁波三星医疗电气股份有限公司 关于为子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 担保对象 被担保人名称 宁波奥克斯智能科技股份有限公司（以 下简称"奥克斯智能科技"） 本次担保金额 111,571.62 万人民币 实际为其提供的担保余额 446,331.62 万元（含本次担保） 是否在前期预计额度内 是 □否 □不适用：_________ 本次担保是否有反担保 □是 否 □不适用：_________ 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 975,350.00 | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 80.73% | | 100% 特别风险提示（如有请勾选） | □对外担保总额超过最近一期经审计净资产 担保金额超过上市公司最近一期经审计净 | ...

Core Viewpoint - Samsung Medical is committed to advancing its digital transformation strategy to enhance patient experience and medical quality amid the aging population in China [1] Group 1: Financial Performance - For the period from January to September, Samsung Medical achieved a revenue of 11.08 billion yuan, representing a year-on-year growth of 6.19% [1] - The company reported a net profit attributable to shareholders of 1.528 billion yuan, which reflects a year-on-year decline of 15.85% [1] Group 2: Strategic Focus - The company is focusing on chain operations, discipline construction, and medical quality to deepen its engagement in the rehabilitation sector [1] - Continuous improvement in management and operational levels is a priority for the company [1]

证券日报网讯 12月18日，三星医疗（601567）在互动平台回答投资者提问时表示，公司坚定不移地推 进数字化转型战略，提升患者体验和医疗质量。在国内老龄化趋势下，公司重点围绕连锁经营、学科建 设、医疗质量等方面，持续深耕康复领域，不断提高管理运营水平。 ...

Group 1 - The high-pressure oxygen chamber concept increased by 2.20%, ranking fourth among concept sectors, with eight stocks rising, including Jinling Pharmaceutical, BeiYikang, and Innovation Medical, which rose by 6.35%, 5.73%, and 3.79% respectively [1] - The main capital inflow for the high-pressure oxygen chamber concept was 0.29 billion yuan, with five stocks receiving net inflows, led by Innovation Medical with a net inflow of 52.09 million yuan [2][3] - The net inflow ratios for International Medical, Innovation Medical, and Jinling Pharmaceutical were 9.48%, 5.21%, and 3.12% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical, International Medical, and Jinling Pharmaceutical, while the top losers were Samsung Medical and Hangyang Co., which fell by 3.20% and 1.14% respectively [1][4] - The trading volume for Innovation Medical was 11.31%, indicating a high turnover rate, while other stocks like International Medical and Jinling Pharmaceutical had lower turnover rates of 1.77% and 4.54% respectively [3]

Group 1 - The total installed power generation capacity in China is expected to exceed 3.8 billion kilowatts in 2026, representing a year-on-year growth of 14% [1] - The total electricity consumption in China has surpassed 10 trillion kilowatt-hours for the first time, marking a significant milestone in the country's economic and energy development [1] - The energy self-sufficiency rate in China has increased from around 80% to over 84% since the start of the 14th Five-Year Plan, establishing the largest renewable energy system globally [1] Group 2 - The rapid development of artificial intelligence has led to a surge in electricity demand, with internet data service electricity consumption increasing by 43% year-on-year from January to October [1] - Citibank indicates that global electricity demand is being driven up by AI data centers, electrification, and the integration of renewable energy, alongside a reduction in financing costs due to the Federal Reserve's interest rate cuts [1] - Domestic policies are reinforcing long-term opportunities in ultra-high voltage, flexible DC transmission, and smart grid sectors, with structural demand continuing to emerge [2] Group 3 - The construction of a unified national electricity market is accelerating, with expected grid investments during the 15th Five-Year Plan projected to exceed 4 trillion yuan, significantly higher than the 2.8 trillion yuan during the 14th Five-Year Plan [2] - The A-share electric grid equipment index has risen by 31.28% year-to-date, outperforming the Shanghai Composite Index by over 17 percentage points [2] - Ten electric grid equipment stocks have seen cumulative gains exceeding 100% this year, with Huatong Cable leading at nearly 200% [2] Group 4 - According to Wind's consensus forecast, 12 electric grid equipment stocks are expected to have net profit growth rates exceeding 20% in both 2026 and 2027 [3] - Far East Holdings is projected to have the highest average net profit growth rate of 48.89% over the next two years, with significant contributions from its AI-related products [3] - Three of the high-growth potential electric grid stocks have rolling P/E ratios below 30, including Samsung Medical, which has a rolling P/E of 17.11 [3]

Investment Rating - The report maintains a "Buy" rating for key companies in the power and coal sectors, including Harbin Electric, China Shenhua, and Zhongmei Energy [7][9][30]. Core Insights - The electricity demand in November 2025 is expected to continue its high growth rate, with a projected increase of 6.6% year-on-year, reaching 8,364 billion kWh [1]. - The report highlights a significant rebound in exports, particularly in integrated circuits and automobiles, which is expected to support electricity demand growth [3]. - The heating season is anticipated to be longer this year due to the late timing of the Spring Festival, potentially leading to higher-than-expected heating demand [4]. - The report emphasizes the resilience of domestic demand driven by government policies aimed at stabilizing growth and reducing competition [5]. Summary by Sections Electricity Generation Forecast - The estimated national electricity generation for November 2025 is 7,898 billion kWh, reflecting a year-on-year increase of 3.9% [1][10]. - The breakdown of generation includes thermal power at 5,069 billion kWh (down 2.1%), hydropower at 1,138 billion kWh (up 38.3%), wind power at 955 billion kWh (up 16.0%), solar power at 336 billion kWh (up 12.8%), and nuclear power at 400 billion kWh (up 6.4%) [10][14]. Coal Consumption Trends - Thermal coal consumption has shown a decline, with coastal provinces averaging 1.84 million tons per day (down 2.5% year-on-year) and inland provinces averaging 3.35 million tons per day (down 5.6% year-on-year) [2][10]. - The report suggests that improved water conditions and seasonal wind energy output may lead to a reduction in thermal power generation [2]. Company Recommendations - Harbin Electric is recommended due to its leading position in traditional power equipment and expected benefits from ongoing nuclear power approvals and global electricity shortages [30]. - Zhongmei Energy is highlighted for its effective cost control and expected recovery in coal prices, maintaining a "Buy" rating [31]. - China Shenhua is noted for its strong cost management and improved profitability, with a target price increase to 51.3 yuan [35]. Market Outlook - The report anticipates that electricity demand will outpace GDP growth for the year, supported by both domestic and export recovery [5]. - The potential for higher-than-expected coal demand during the heating season is emphasized, suggesting a bullish outlook for coal prices [4][5].

Core Viewpoint - Samsung Medical (601567) announced that its wholly-owned subsidiary, Aux Smart Technology, has been recommended as a candidate for winning a bid in a procurement project by the State Grid Corporation of China, with a total expected bid amount of approximately 108.43 million yuan [1] Group 1 - The procurement project involves overhead insulated wires, 10kV transformers, and complete sets of 10kV pole-mounted transformer equipment [1] - The project is part of the State Grid's 2025 joint procurement for the Northwest and Tibet regions [1]